Showing results (101-110 of 116) with videos related to

Sort By:
Pageof 12
The American Journal of Surgical Pathology|December 1, 1996
Tissue-shrinkage correction factor in the calculation of prostate cancer volumeA R Schned, K J Wheeler, C A Hodorowski, et al.
Preventive Medicine Reports|August 17, 2021
An in-depth comparison of well-being among Latinx and non-Latinx White adults: A cautionary talePatricia Rodriguez Espinosa, Michele L Patel, Abby C King, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 1, 1995
Fatal genitourinary mucormycosis in a patient with undiagnosed diabetesJ C Williams, A R Schned, J R Richardson, et al.
Health Education Quarterly|August 1, 1995
Evaluation of health education programs: current assessment and future directionsB A Israel, K M Cummings, M B Dignan, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|May 21, 2016
Adaptation and validation of the Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR) for the NetherlandsM Wapenaar, J Twiss, M Wagenaar, et al.
Cancer Research|June 30, 2001
Mutational analysis of the peroxisome proliferator-activated receptor gamma gene in human malignanciesT Ikezoe, C W Miller, S Kawano, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|October 28, 2018
Correction to: Adaptation and validation of the Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR) for the NetherlandsM Wapenaar, J Twiss, M Wagenaar, et al.
Clinical Immunology (Orlando, Fla.)|July 20, 2005
Impaired cytolytic activity in peripheral blood T cells from renal cell carcinoma patientsTodd S Crocenzi, Christopher P G Tretter, Thomas Schwaab, et al.
BMC Public Health|February 5, 2020
Exploring health and well-being in Taiwan: what we can learn from individuals' narrativesPatricia Rodriguez Espinosa, Yong-Chen Chen, Chien-An Sun, et al.
The Journal of Urology|March 29, 2000
A randomized phase II trial comparing two different sequence combinations of autologous vaccine and human recombinant interferon gamma and human recombinant interferon alpha2B therapy in patients with metastatic renal cell carcinoma: clinical outcome and analysis of immunological parametersT Schwaab, J A Heaney, A R Schned, et al.
Pageof 12